Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

DSpace Repository

Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

Author: Tengelmann, Caroline; Joos, Stefanie; Kaussner, Yvonne; Malzahn, Uwe; Lunden, Laura; Klug, Andreas; Hausler, Karl Georg; Escales, Catharina; Maetzler, Walter; Hugen, Klemens; Zolk, Oliver; Heuschmann, Peter U.; Forster, Christian; Kaduszkiewicz, Hanna; Gagyor, Ildiko
Tübinger Autor(en):
Joos, Stefanie
Förster, Christian
Published in: Bmc Infectious Diseases (2024), Bd. 24 (1), Article 56
Verlagsangabe: London : Bmc
Language: English
Full text: http://dx.doi.org/10.1186/s12879-023-08925-2
ISSN: 1471-2334
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)